当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析 - 现金流量表

亚宝药业

(600351)

  

流通市值:47.47亿  总市值:47.47亿
流通股本:6.92亿   总股本:6.92亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,639,675,251.491,129,022,660.04516,562,193.192,492,397,912.06
  收到的税费返还862,526.88583,589.32547,328.772,490,160.3
  收到其他与经营活动有关的现金115,483,977.4165,433,405.3538,896,430.7992,124,130.89
  经营活动现金流入小计1,756,021,755.781,195,039,654.71556,005,952.752,587,012,203.25
  购买商品、接受劳务支付的现金448,038,662.1311,243,959.25145,026,495.41722,482,479.63
  支付给职工以及为职工支付的现金314,652,788.51222,811,731.74115,493,585.23473,276,788.59
  支付的各项税费177,425,795.24113,156,905.2748,948,776.86289,222,439.78
  支付其他与经营活动有关的现金359,242,436.54220,528,164.25102,138,566.8630,335,922.43
  经营活动现金流出小计1,299,359,682.39867,740,760.51411,607,424.32,115,317,630.43
  经营活动产生的现金流量净额456,662,073.39327,298,894.2144,398,528.45471,694,572.82
二、投资活动产生的现金流量:
  收回投资收到的现金144,773,736.1710,281,476.485,089,553.8921,425,839.33
  取得投资收益收到的现金666,832.96544,865.42-2,475,445.77
  处置固定资产、无形资产和其他长期资产收回的现金净额201,526.85188,076.85101,400903,324.42
  投资活动现金流入小计145,642,095.9811,014,418.755,190,953.8924,804,609.52
  购建固定资产、无形资产和其他长期资产支付的现金38,768,594.9931,185,757.2515,255,253.2534,661,989.74
  投资支付的现金151,449,511.0624,246,600.9616,792,475.8723,789,822.83
  取得子公司及其他营业单位支付的现金---5,000
  投资活动现金流出小计190,218,106.0555,432,358.2132,047,729.1258,456,812.57
  投资活动产生的现金流量净额-44,576,010.07-44,417,939.46-26,856,775.23-33,652,203.05
三、筹资活动产生的现金流量:
  取得借款收到的现金190,000,000140,000,00090,000,00090,000,000
  收到其他与筹资活动有关的现金3,982,865.04--43,742,947.96
  筹资活动现金流入小计193,982,865.04140,000,00090,000,000133,742,947.96
  偿还债务支付的现金180,000,00090,000,00090,000,000202,000,000
  分配股利、利润或偿付利息支付的现金225,225,627.29209,559,835.62616,375113,565,124.57
  其中:子公司支付给少数股东的股利、利润15,300,000---
  支付其他与筹资活动有关的现金133,745,772.5960,670,612.4259,970,083.42243,444,339.36
  筹资活动现金流出小计538,971,399.88360,230,448.04150,586,458.42559,009,463.93
  筹资活动产生的现金流量净额-344,988,534.84-220,230,448.04-60,586,458.42-425,266,515.97
四、汇率变动对现金及现金等价物的影响52,353.0750,273.0441,220.918,404.69
五、现金及现金等价物净增加额67,149,881.5562,700,779.7456,996,515.712,794,258.49
  加:期初现金及现金等价物余额578,258,001.1578,258,001.1578,258,001.1565,463,742.61
  期末现金及现金等价物余额645,407,882.65640,958,780.84635,254,516.8578,258,001.1
补充资料:
  净利润-175,188,416.73-223,915,500.69
  资产减值准备-10,010,853.29-42,162,919.81
  固定资产和投资性房地产折旧-60,600,270.96-123,986,985.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-60,600,270.96-123,986,985.53
  无形资产摊销-5,948,709.36-12,356,240.31
  长期待摊费用摊销-286,804.8-579,112.86
  处置固定资产、无形资产和其他长期资产的损失--50,194.26--347,086.9
  固定资产报废损失--16,491.61-3,441,210.31
  公允价值变动损失--419,744.99-2,847,479.62
  财务费用-1,168,645.37-5,928,731.15
  投资损失--992,783.8-188,362.77
  递延所得税-1,022,216.45--10,723,715.64
  其中:递延所得税资产减少-1,367,098.32--10,465,396.81
    递延所得税负债增加--344,881.87--258,318.83
  存货的减少-49,586,821.67-11,003,212.84
  经营性应收项目的减少-63,764,586.72-93,269,142.31
  经营性应付项目的增加--33,038,387.27--36,195,344.46
  不涉及现金收支的投资和筹资活动金额其他项目---4,269,285.28
  现金的期末余额-640,958,780.84-578,258,001.1
  减:现金的期初余额-578,258,001.1-565,463,742.61
  现金及现金等价物的净增加额-62,700,779.74-12,794,258.49
公告日期2025-10-252025-08-162025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑